CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
Centogene N.V. - Common Shares (CNTG)
Last centogene n.v. - common shares earnings: 12/5 06:28 am
Check Earnings Report
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, announced today a new data access and collaboration agreement with Pfizer Inc. (NYSE: PFE). The agreement grants Pfizer access to CENTOGENE’s data repository, which may be used in the discovery and validation of novel genetic and biochemical targets for the potential development of new therapies for rare diseases. “With what we believe to be the world’s largest data repository of epidemiologic, phenotypic and clinical data in orphan diseases, CENTOGENE is fuelling the global knowledge base of rare disease patient populations,” explains Arndt Rolfs, CEO of CENTOGENE. “The potential for furthering the understanding of rare disease is extremely important for patients around the world, and we
Show less
Read more
Impact Snapshot
Event Time:
CNTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNTG alerts
High impacting Centogene N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
CNTG
News
- CENTOGENE Receives Delisting Notice From Nasdaq [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Receives Delisting Notice From NasdaqGlobeNewswire
- CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic Factors [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic FactorsGlobeNewswire
- Europe Clinical Biomarkers Market Analysis and Forecast Report 2024, Featuring ALCEN, bioMerieux, Centogene, Eurofins Scientific, F. Hoffmann-La Roche and Qiagen [Yahoo! Finance]Yahoo! Finance
CNTG
Sec Filings
- 8/8/24 - Form 6-K
- 8/1/24 - Form 6-K
- CNTG's page on the SEC website